Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial

Journal:
Nature Medicine
Published:
Affiliations:
22
Authors:
36
Institutions Authors Share
NIH National Cancer Institute (NCI), United States of America (USA)
10.000000
10.000000
0.28
Children's Hospital of Philadelphia (CHOP), United States of America (USA)
6.000000
0.17
Dana-Farber/Boston Children's Cancer and Blood Disorders Center, United States of America (USA)
4.000000
0.11
University of Michigan Rogel Cancer Center, United States of America (USA)
3.000000
0.08
University of Michigan (U-M), United States of America (USA)
2.000000
0.06
C.S. Mott Children's Hospital, U-M, United States of America (USA)
1.000000
0.03
Weill Cornell Medicine, United States of America (USA)
1.000000
0.03
Mayo Clinic, United States of America (USA)
1.000000
0.03
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)
1.000000
0.03
The University of Iowa (UI), United States of America (USA)
1.000000
0.03
USC Children’s Center for Cancer and Blood Diseases (CCCBD), CHLA, United States of America (USA)
1.000000
0.03
OSU Department of Pediatrics (Nationwide Children's Hospital), United States of America (USA)
1.000000
0.03
Sarcoma Alliance for Research Through Collaboration (SARC), United States of America (USA)
1.000000
0.03
University of Pennsylvania (Penn), United States of America (USA)
1.000000
0.03
Cedars-Sinai Guerin Children’s, United States of America (USA)
0.500000
0.01
Samuel Oschin Cancer Center, United States of America (USA)
0.500000
0.01
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA)
0.500000
0.01
Children's Hospital Colorado, United States of America (USA)
0.500000
0.01